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Abstract
Background While Campylobacter jejuni represents the most common cause of bacterial gastroenteritis, Yersinia pseudo-
tuberculosis infections are very rarely diagnosed in adults.
Case We report on a previously healthy patient who presented several times at our hospital with fever, Guillain-Barré 
syndrome, recurrent abdominal symptoms and distinct mesenteric lymphadenopathy, respectively. This complicated and 
diagnostically challenging course of disease was caused by a C. jejuni and Y. pseudotuberculosis coinfection. Antibiotic 
treatment with doxycycline was effective.
Conclusion Broad serology testing was crucial to discover that two concomitant infections were causing the symptoms. This 
case demonstrates that when a clinical picture is not fully explained by one known infection, another infection with the same 
underlying risk factor has to be considered, hence “a horse and a zebra”.
Keywords Campylobacter jejuni · Yersinia pseudotuberculosis · Guillain-Barré syndrome · Mesenteric lymphadenopathy · 
Mesenteric lymphadenitis · Pseudoappendicitis
Case report
A 28-year-old Caucasian male presented with fever and 
myalgia at our emergency department (= day 1). The patient 
reported having been on vacation on La Réunion until nine 
days prior, where a medium-level dengue epidemic had been 
declared by the WHO. His past medical history was unevent-
ful; he was not on any medication. Physical examination 
revealed a body temperature of 39.7 °C but was otherwise 
unremarkable. Routine laboratory investigations were with-
out pathological findings except for a C-reactive protein 
(CRP) of 2.5 mg/dl. Tests for Dengue virus and Chikungu-
nya virus were ordered. The patient received metamizole 
and was discharged with a daily follow-up schedule which, 
however, he did not comply with. The microbiological labo-
ratory tests returned negative. After three days, fever sub-
sided and was followed by watery diarrhoea which lasted for 
three more days. On day 7, the patient had fully recovered.
On day 8, the patient noticed a weakness in his lower 
limbs which continuously worsened overnight. Thus, he pre-
sented in our neurological clinic the next morning. Physi-
cal examination revealed flaccid tetraparesis with a level of 
strength of 4/5 (MRC scale). Muscle reflexes of the upper 
limbs and patellar reflexes were decreased, Achilles reflexes 
were absent bilaterally. There were no sensory deficits; posi-
tion sense and vibration sense were intact. Cerebrospinal 
fluid analysis was unremarkable. Electroneurography dis-
closed reduced amplitudes of compound muscle action 
potentials in tibial, peroneal and ulnar nerves. Half of the 
examined nerves displayed increased distal motor latency 
and total loss of F-waves, while sensory nerve action 
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potentials were normal all over. Hence, pure motor axonal 
demyelinating polyneuropathy with acute onset, consistent 
with Guillain-Barré syndrome (GBS) was diagnosed. Fur-
thermore, western blot for serum anti-ganglioside antibodies 
was highly positive for anti-GM2 IgM antibodies and bor-
derline positive for anti-GM1 IgM antibodies, thus support-
ing the diagnosis of GBS. The occurrence of GBS raised the 
suspicion of a recent Campylobacter jejuni infection which 
was serologically confirmed (Mycoplasma pneumonia, 
another common trigger of GBS, and Zika virus infection 
were excluded).
As the clinical condition deteriorated rapidly with inabil-
ity to walk occurring within the first 48 h, treatment with 
intravenous immunoglobulins was initiated (total dose 140 g 
over 5 days). Clinical nadir was reached after three days and 
the patient regained independent walking within the first 
week. He was transferred to a neurorehabilitation institution 
where he was treated for three weeks. Except for a tempo-
rary elevation of transaminases (ALT 661 U/l, AST 126 U/l) 
and a distortion of the left knee due to several falls, further 
recovery proceeded without complications.
In week 10, the patient presented at our clinic again. He 
complained of fever, loss of appetite, abdominal bloating, 
constipation and a dull pain in the right lower abdomen. He 
reported suffering from these symptoms periodically; they 
had first occurred three weeks ago and lasted for a couple of 
days, then completely disappeared and reoccurred six days 
ago. The onset as well as the disappearance of these symp-
toms was sudden. On enquiry, the patient could not think of 
any potential triggers preceding these episodes. Diarrhoea 
had not occurred.
The patient’s vital signs were all normal except for a 
body temperature of 38.8 °C. Compared to his first presen-
tation, he had lost 11 kg (15% of his previous body weight). 
The abdominal examination was pertinent for tenderness 
on palpation in the right lower quadrant. Broad laboratory 
investigations were unremarkable apart from an elevated 
CRP of 8.5 mg/dl and a slightly elevated LDH. Abdominal 
ultrasound revealed a distinct mesenteric lymphadenopa-
thy with > 10 pathological lymph nodes (max. 4 × 1.6 cm) 
(Fig. 1). The largest mesenteric lymph nodes were found in 
the right lower quadrant and were painful when pressed with 
the ultrasound probe. Retroperitoneal, inguinal, supraclavic-
ular, axillary and cervical lymph nodes as well as the appen-
dix and colon appeared normal on ultrasound examination.
A broad microbiological testing was initiated. While 
stool cultures remained negative, serology was positive for 
Y. pseudotuberculosis (Table 1). Antibiotic treatment was 
initially started with azithromycin (500 mg p.o., QD, for 3 
days) and switched to doxycycline (100 mg p.o., BID, for 
10 days) after receiving the serology results.
On control ultrasound two weeks later (week 12), the 
lymphadenopathy was clearly regressive in all affected 
regions with the largest mesenteric lymphnode measuring 
2 × 0.7 cm. In a telephone follow-up two months later, the 
patient reported no further episodes of fever or abdominal 
symptoms. Regarding GBS, he had not regained his full 
physical capacity but continued to improve constantly.
Discussion
Campylobacter jejuni is a Gram-negative, rod-shaped bac-
terium that naturally colonizes the digestive track of both 
wildlife and domestic farm animals [1]. It usually infects 
humans through the ingestion of contaminated meat and 
poultry [2, 3]. Rarely, infections also occur through inges-
tion of contaminated water, uncooked milk or via person-to-
person transmission [2]. Incubation time is commonly less 
than five days but can range up to ten days [4] with a lower 
infection dose possibly leading to longer incubation time 
[5]. As it was the case in our patient, campylobacteriosis 
often sets in with unspecific, flu-like prodromal symptoms 
lasting for 1 or 2 days. This is followed by acute enteritis 
with watery diarrhoea and sometimes crampy abdominal 
pain that lasts six days on average. The infection is usu-
ally self-limiting and does not require specific treatment, 
however, it can lead to severe immunological complications. 
Due to molecular mimicry between its lipooligosaccharides 
and host gangliosides, C. jejuni is the major trigger of GBS 
[6]. Here, it is associated with a pure motor syndrome, as it 
occurred in our patient, and a slower recovery [7]. C. jejuni 
is the most common cause of bacterial gastroenteritis in 
developed countries (e.g., estimated incidence in Germany: 
53-81/100,000 persons/year [8]). The prevalence in devel-
oping countries is even higher, making it the most frequent 
travel associated enteric infection [9].
Yersinia pseudotuberculosis on the other hand is a very 
rare cause of enteric disease. The number of diagnosed cases 
varies strongly in different studies (Finland: 0.6–0.8/100,000 
persons/year [10]; USA: 0.04/1,000,000 persons [11]; Ger-
many: 0.03/100,000 persons/year [12]). Y. pseudotubercu-
losis is a Gram-negative, exotoxin producing rod [13]. It can 
be found ubiquitously in various animals including birds, 
game animals and pigs [14]. Outbreaks have been linked 
to the ingestion of fresh produce as well [10, 14]. This is 
certainly favoured by the species’ resilience to extremes of 
temperature and minimal nutritional requirements [13]. In 
humans, the infection leads to different symptoms depend-
ing on the patient’s age and the geographical origin of the 
strain. Symptoms of infection caused by strains predominant 
in Europe are fever, acute terminal ileitis (pseudoappendi-
citis) and mesenteric lymphadenitis. Notably, these symp-
toms mostly occur in children and young adults [12]. Due 
to different virulence factors, endemic strains in far-eastern 
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Fig. 1  Abdominal ultrasound examination reveals multiple enlarged 
mesenteric lymph nodes in the right lower quadrant. a Hypoechoic 
lymph nodes surrounded by hyperechoic mesenteric tissue. b Diam-
eters of the two largest oval shaped lymph nodes (max. diameter 
4 cm). c Hilus perfusion of the lymph nodes depicted by duplex ultra-
sound
Table 1  Results of 
anti-C. jejuni- and 
anti-Y. pseudotuberculosis-
antibody testing from sera 
sampled at three different time 
points during the course of 
disease
For this retrospective comparison, parallel testing of all sera was performed. Upwards and downwards 
arrows indicate a significant (min. fourfold) increase and decrease in titers, respectively
C. jejuni Y. pseudotuberculosis
Blot ELISA Blot Widal test
IgA IgG IgA IgG IgA IgG
Week 1 (occurrence of GBS) Positive Positive Positive Positive Negative Negative Negative






Week 12 (follow-up visit) Negative Positive Negative Negative Positive Positive Borderline
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Russia and Asia also cause scarlatiniform rash, desquama-
tion and erythema nodosum [15]. Incubation time is com-
monly 5–10 days but can be as long as 21 days [16].
The incubation time in our patient seemed to differ, 
making this cases chronological sequence remarkable. It is 
extremely unlikely that these two infections, one of them 
very rare, occurred within few weeks in an immunocom-
petent person without any correlation between each other. 
However, poor food hygiene is the common main risk factor 
for both infections. Moreover, pig herds have been shown 
to carry both Campylobacter spp. and Yersinia spp.[17]. 
Therefore, we considered a simultaneous infection to be 
most probable. Assuming this, the incubation time until the 
first symptoms presumably associated with Y. pseudotuber-
culosis occurred would have been at least seven weeks. This 
seems astonishingly long, however, during an outbreak of Y. 
pseudotuberculosis length of illnesses up to six months were 
observed with symptoms occurring later in adults than in 
children [18]. This is probably due to the species’ ability to 
colonize and persist in intestinal and lymph tissues with the 
aid of specific outer membrane proteins [19].
In addition, antibody titres to Y.  pseudotuberculo-
sis were shown to rise particularly late in many patients 
[18, 20]. This matches the serological findings in our case 
well. Neither C. jejuni nor Y. pseudotuberculosis was iso-
lated from stool cultures, probably because the patient did 
not present while having acute diarrhoea. Typically, by the 
time GBS occurs serology is more sensitive for diagnosing 
a recent C. jejuni infection than stool cultures [5].
The overlap of two concomitant infectious diseases result-
ing in a complex clinical picture not attributable to any spe-
cific entity made this case a diagnostic challenge. Following 
the principal that “when hearing hoofbeats, one should think 
of a horse not a zebra”, the obvious suspicion was that a per-
sisting campylobacteriosis caused the recurrent abdominal 
symptoms and fever. Nevertheless, other symptoms like the 
extensive lymphadenopathy did not seem to fit in. Retrospec-
tively, however, it became clear that two different infections 
had presented in an absolutely exemplary way. This is par-
ticularly remarkable for the Y. pseudotuberculosis infection 
whose full clinical picture is very rarely found in adults. This 
case demonstrates that in a patient with one known infection, 
another infection with the same underlying risk factor should 
always be taken into account. Therefore, sometimes both “a 
horse and a zebra” have to be considered.
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